antihemophilic factor

(redirected from ReFacto)
Also found in: Thesaurus, Medical, Encyclopedia.

an·ti·he·mo·phil·ic factor

 (ăn′tē-hē′mə-fĭl′ĭk, ăn′tī-)
n. Abbr. AHF
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.antihemophilic factor - a coagulation factor (trade name Hemofil) whose absence is associated with hemophilia Aantihemophilic factor - a coagulation factor (trade name Hemofil) whose absence is associated with hemophilia A
clotting factor, coagulation factor - any of the factors in the blood whose actions are essential for blood coagulation
References in periodicals archive ?
Sobi has extended the existing manufacturing agreement with Pfizer for the drug substance for ReFacto AF/XYNTHA.
M2 PHARMA-February 16, 2012-Sobi and Pfizer extend supply agreement for ReFacto AF/XYNTHA(C)2012 M2 COMMUNICATIONS
Last month, Sobi, which markets hemophilia A drug ReFacto AF in the Nordic region under a collaboration with Pfizer, unveiled a number of planned cost-saving measures, including 70 job cuts, mainly in preclinical research and manufacturing.
The company also offers the cardiovascular drugs Cordarone, Veralan and Zinc; Lodine, Oruvail and Naprelan, antiarthritic medications; the anti-infectives Suprax and Minocin; and Refacto, a factor VIII treatment for hemophilia A.
Factor product brand names by type Plasma-free Recombinant factor Refacto, Helixate FS, Kogenate FS, VIII Advate Recombinant Factor VIII Recombinate (PRODUCTS NO LONGER MANUFACTURED: BIOCLATE, HELIXATE, KOGENATE) Plasma-derived Factor VIII Hemofil M, Monarch M, Monoclate P, Alphanate, Humate P, Koate DVI Plasma-Derived von Willebrand- Humate P (may also use Koate DVI containing Factor VIII or Alphanate which contain von Willebrand Factor but are assayed in factor VIII units) Recombinant Factor IX Benefix Plasma-Derived Factor IX Alphanine, Mononine Desmopressin DDAVP, Stimate